glucagon has been researched along with bromocriptine in 12 studies
| Studies (glucagon) | Trials (glucagon) | Recent Studies (post-2010) (glucagon) | Studies (bromocriptine) | Trials (bromocriptine) | Recent Studies (post-2010) (bromocriptine) |
|---|---|---|---|---|---|
| 26,039 | 1,498 | 3,054 | 7,121 | 727 | 499 |
| Protein | Taxonomy | glucagon (IC50) | bromocriptine (IC50) |
|---|---|---|---|
| 5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | 0.532 | |
| Beta-1 adrenergic receptor | Homo sapiens (human) | 2.4 | |
| Cytochrome P450 3A4 | Homo sapiens (human) | 2.4996 | |
| Alpha-2A adrenergic receptor | Homo sapiens (human) | 0.015 | |
| D(2) dopamine receptor | Homo sapiens (human) | 0.0016 | |
| Androgen receptor | Rattus norvegicus (Norway rat) | 2.281 | |
| Alpha-2B adrenergic receptor | Homo sapiens (human) | 0.035 | |
| Alpha-2C adrenergic receptor | Homo sapiens (human) | 0.52 | |
| D | Rattus norvegicus (Norway rat) | 0.0279 | |
| D(3) dopamine receptor | Rattus norvegicus (Norway rat) | 0.0279 | |
| 5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 0.0056 | |
| Alpha-2B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.514 | |
| D(1A) dopamine receptor | Homo sapiens (human) | 2.889 | |
| Alpha-2C adrenergic receptor | Rattus norvegicus (Norway rat) | 0.514 | |
| Alpha-2A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.514 | |
| Alpha-1D adrenergic receptor | Homo sapiens (human) | 0.03 | |
| D(1B) dopamine receptor | Rattus norvegicus (Norway rat) | 0.0279 | |
| 5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 0.036 | |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 0.532 | |
| 5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | 0.0056 | |
| D(4) dopamine receptor | Rattus norvegicus (Norway rat) | 0.0279 | |
| D(3) dopamine receptor | Homo sapiens (human) | 0.0006 | |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 0.0083 | |
| 5-hydroxytryptamine receptor 6 | Homo sapiens (human) | 0.022 | |
| D(2) dopamine receptor | Rattus norvegicus (Norway rat) | 0.0279 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (75.00) | 18.7374 |
| 1990's | 2 (16.67) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Komatsu, M; Saito, S | 1 |
| Dieguez, C; Foord, SM; Hall, R; Peters, JR; Scanlon, MF; Shewring, G | 1 |
| Cabezas-Cerrato, J; De la Fuente, A; García López, JM; Gaudiero, GJ; Mato Mato, JA; Odriozola, A; Tomé, MA | 1 |
| Gautvik, K; Haug, E; Johansen, PW; Knudtzon, J | 1 |
| Djordjević, P; Djurić, DS; Micić, D; Mićić, J; Nesović, M; Popović, V | 1 |
| Balsano, F; De Mattia, G; Fini, O; Laurenti, O | 1 |
| Braunstein, GD; Carlson, HE; Hershman, JM; Levin, SR; Spencer, EM; Wilson, SE | 1 |
| Molitvoslovova, NN | 1 |
| Chiba, T; Chihara, K; Fujita, T; Goto, B; Kadowaki, S; Matsukura, S; Minamitani, N; Taminato, T | 1 |
| Dolecek, R; Kubis, M; Sajnar, J; Závada, M | 1 |
| Ahlenius, S; Alster, P; Hillegaart, V; Uvnäs-Moberg, K | 1 |
| Cincotta, AH; Liang, Y | 1 |
12 other study(ies) available for glucagon and bromocriptine
| Article | Year |
|---|---|
[Glucose intolerance in pituitary disease].
Topics: Acromegaly; Bromocriptine; Cushing Syndrome; Glucagon; Gluconeogenesis; Glucose; Glucose Tolerance Test; Humans; Hypopituitarism; Insulin Resistance; Liver | 1991 |
Thyrotropin regulates thyrotroph responsiveness to dopamine in vitro.
Topics: Adrenocorticotropic Hormone; Animals; Bromocriptine; Chorionic Gonadotropin; Culture Media; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Glucagon; Hot Temperature; Hypothyroidism; Insulin; Male; Pituitary Gland, Anterior; Prolactin; Rats; Rats, Inbred Strains; Receptors, Dopamine; Thyrotropin; Time Factors | 1986 |
Acromegaly and insulin resistance: a case study.
Topics: Acromegaly; Adenoma, Acidophil; Bromocriptine; C-Peptide; Female; Glucagon; Glucose; Glucose Tolerance Test; Growth Hormone; Humans; Insulin; Insulin Resistance; Middle Aged; Pituitary Neoplasms; Tomography, X-Ray Computed | 1986 |
Effects of hypersecretion of growth hormone and prolactin on plasma levels of glucagon and insulin in GH3-cell-tumor-bearing rats, and the influence of bromocriptine treatment.
Topics: Animals; Blood Glucose; Body Weight; Bromocriptine; Cell Line; Female; Glucagon; Growth Hormone; Insulin; Male; Neoplasms, Experimental; Prolactin; Rats; Rats, Inbred WF | 1986 |
Chronic bromocriptine treatment and glucose intolerance in acromegaly.
Topics: Acromegaly; Adult; Blood Glucose; Bromocriptine; Diabetes Complications; Diabetes Mellitus; Female; Glucagon; Glucose Tolerance Test; Growth Hormone; Humans; Insulin; Male; Middle Aged | 1985 |
[Effects of 2-bromo-alpha-ergocryptine in diabetic subjects].
Topics: Adult; Aged; Bromocriptine; Diabetes Mellitus; Female; Glucagon; Growth Hormone; Humans; Insulin; Male; Middle Aged | 1983 |
Effect of bromocriptine on serum hormones in acromegaly.
Topics: Acromegaly; Adult; Aged; Blood Glucose; Bromocriptine; Female; Glucagon; Growth Hormone; Hormones; Humans; Insulin; Male; Middle Aged; Prolactin; Radioimmunoassay; Radioligand Assay; Somatomedins; Thyrotropin; Thyrotropin-Releasing Hormone | 1984 |
[Effect of parlodel on carbohydrate metabolism regulation in acromegaly].
Topics: Acromegaly; Adult; Bromocriptine; C-Peptide; Carbohydrates; Diabetes Mellitus; Drug Evaluation; Female; Glucagon; Glucose Tolerance Test; Growth Hormone; Humans; Insulin Antibodies; Male; Middle Aged; Pancreas | 1984 |
Effect of long term bromocriptine treatment on glucose intolerance in acromegaly.
Topics: Acromegaly; Adult; Aged; Blood Glucose; Bromocriptine; Female; Glucagon; Glucose Tolerance Test; Growth Hormone; Humans; Insulin; Kinetics; Male; Middle Aged | 1982 |
Bromocriptine and glucose tolerance in acromegalics.
Topics: Acromegaly; Blood Glucose; Bromocriptine; Glucagon; Glucose Tolerance Test; Growth Hormone; Humans; Insulin | 1982 |
Effects of selective serotonin and dopamine agonists on plasma levels of glucose, insulin and glucagon in the rat.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Blood Glucose; Bromocriptine; Buspirone; Dopamine Agonists; Ergolines; Glucagon; Insulin; Male; Quinpirole; Rats; Rats, Sprague-Dawley; Serotonin Receptor Agonists; Tetrahydronaphthalenes | 1996 |
Increased responsiveness to the hyperglycemic, hyperglucagonemic and hyperinsulinemic effects of circulating norepinephrine in ob/ob mice.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adrenergic alpha-Agonists; Animals; Blood Glucose; Bromocriptine; Dopamine Agonists; Female; Glucagon; Glucose Clamp Technique; Hyperglycemia; Hyperinsulinism; Insulin; Insulin Secretion; Mice; Mice, Inbred C57BL; Mice, Obese; Norepinephrine; Random Allocation | 2001 |